Genekine is a biotechnology enterprise focusing on the research and development of macromolecular drugs.
Genekine is a biotechnology enterprise focusing on the research and development of macromolecular drugs. Genekine conducts research and industrialization of new protein expression systems based on genetic engineering, protein engineering and glycoengineering, and other related biotechnologies.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 27, 2018 | Funding Round | — | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
|
— | Funding Round |
![]() |
— | Funding Round |